BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8529465)

  • 1. Assessing sequential oncogene amplification in human breast cancer.
    Janocko LE; Lucke JF; Groft DW; Brown KA; Smith CA; Pollice AA; Singh SG; Yakulis R; Hartsock RJ; Shackney SE
    Cytometry; 1995 Sep; 21(1):18-22. PubMed ID: 8529465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
    Persons DL; Borelli KA; Hsu PH
    Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of amplification of proto-oncogenes in breast cancer.
    Chen Y; Dong J; Lu Y; McGee JO
    Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of HER-2/neu/c-erbB-2 gene amplification in benign and malignant breast disease.
    Supanaranond K; Sukarayodhin S; Tanyakaset M; Balachandra K; Jullaksorn D; Rienkijkarn M; Hoisanka N; Tantivanich S
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):631-40. PubMed ID: 9561622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of breast cancer according to the status of HER-2/neu oncogene amplification.
    Huang WY; Newman B; Millikan RC; Conway K; Hulka BS; Schell MJ; Liu ET
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):65-71. PubMed ID: 10667465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
    Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
    Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer.
    Homaei-Shandiz F; Ghavam-Nassiri MR; Sharifi N; Homaei-Shandiz AH; Taghizadeh-Kermani A; Torshizi SA; Ghafarzadegan K
    Saudi Med J; 2006 Dec; 27(12):1810-4. PubMed ID: 17143354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.
    Kreipe H; Feist H; Fischer L; Felgner J; Heidorn K; Mettler L; Parwaresch R
    Cancer Res; 1993 Apr; 53(8):1956-61. PubMed ID: 8096798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal FHIT gene transcript and c-myc and c-erbB2 amplification in breast cancer.
    Kowara R; Gołebiowski F; Chrzan P; Skokowski J; Karmolinski A; Pawełczyk T
    Acta Biochim Pol; 2002; 49(2):341-50. PubMed ID: 12362975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters].
    Lizard-Nacol S; Arnould L; Riedinger JM; Arnal M; Collin F; Guerrin J
    Bull Cancer; 1994 Sep; 81(9):780-4. PubMed ID: 7703567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP; Kacinski B; Validire P; Beuvon F; Sastre X; Benoit P; dela Rochefordière A; Mosseri V; Pouillart P; Scholl S
    J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of the human BSMZ breast cancer cell line, which overexpresses the erbB-2 and c-myc genes.
    Watanabe M; Tanaka H; Kamada M; Okano JH; Takahashi H; Uchida K; Iwamura A; Zeniya M; Ohno T
    Cancer Res; 1992 Oct; 52(19):5178-82. PubMed ID: 1356615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
    Scorilas A; Trangas T; Yotis J; Pateras C; Talieri M
    Br J Cancer; 1999 Dec; 81(8):1385-91. PubMed ID: 10604737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.